Janus Henderson Group PLC Savara Inc Transaction History
Janus Henderson Group PLC
- $182 Billion
- Q2 2024
A detailed history of Janus Henderson Group PLC transactions in Savara Inc stock. As of the latest transaction made, Janus Henderson Group PLC holds 2,276,460 shares of SVRA stock, worth $9.04 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,276,460
Previous 2,563,620
11.2%
Holding current value
$9.04 Million
Previous $12.8 Million
28.14%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding SVRA
# of Institutions
142Shares Held
148MCall Options Held
242KPut Options Held
601K-
Nea Management Company, LLC Timonium, MD24.5MShares$97.2 Million9.31% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA14.6MShares$57.8 Million12.01% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA12.4MShares$49.1 Million7.46% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.16MShares$32.4 Million1.94% of portfolio
-
Black Rock Inc. New York, NY8.03MShares$31.9 Million0.0% of portfolio
About Savara Inc
- Ticker SVRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 114,043,000
- Market Cap $453M
- Description
- Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.